Rankings
▼
Calendar
OABI Q4 2020 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena
OABI
OmniAb, Inc.
$221M
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$13M
Gross Profit
$13M
100.0% margin
Operating Income
-$2M
-18.0% margin
Net Income
-$159,000
-1.2% margin
EPS (Diluted)
$-0.00
QoQ Revenue Growth
+167.3%
Cash Flow
Operating Cash Flow
$2M
Free Cash Flow
$2M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$295M
Total Liabilities
$60M
Stockholders' Equity
$236M
Cash & Equivalents
$0
← FY 2020
All Quarters
Q1 2021 →